-
actively in brainstorming sessions and collaborates meetings with scientists, engineers, and clinicians to develop and refine genome editing strategies for CAR/TCR-T cell therapies. This involves
-
. Experience with large-scale genomic data would also be advantageous. Prior first author publications are highly desirable. Must be self-motivated, well-organized, highly independent, and willing to train new
-
aims to develop and test novel CAR-redirected immunotherapy for pediatric solid tumors. In particular, a CRISPR/Cas9-based mutagenesis screen will be applied to discover and therapeutically target novel
-
present findings at prestigious national/international conferences to prepare for their chosen career path. Application Instructions: Please include a recent CV and the contact information for 2 references
-
-retroviral therapies. Our lab welcomes persons from diverse backgrounds. The candidate will work side-by-side with Dr. Hartig to develop cutting-edge scientific skills as the lab tackles these problems and
-
development activities and in collaborative projects and present findings at a prestigious national/international conference, to prepare for the chosen career. Job Duties Conducts research projects, both
-
field. Strong analytical and written communication skills, including proficiency in presentation and educational content development. Strong interest in neuroethics, psychedelics, bioethics, health policy
-
is to develop innovative immmuno therapies aimed at eradicating endometriotic lesions and effectively alleviating endometriosis-related symptoms, such as infertility and pain. The Post-Doc researcher
-
. Subsequently, our goal is to develop innovative immmuno therapies aimed at eradicating endometriotic lesions and effectively alleviating endometriosis-related symptoms, such as infertility and pain. The Post-Doc
-
: The candidate will develop innovative methods to integrate multiple modalities of single cell data to disentangle cell-to-cell variability, and identify novel cell subpopulations that contribute to treatment